Birchview Capital, LP Liquidia Corp Transaction History
Birchview Capital, LP
- $111 Million
- Q1 2025
A detailed history of Birchview Capital, LP transactions in Liquidia Corp stock. As of the latest transaction made, Birchview Capital, LP holds 10,013 shares of LQDA stock, worth $204,765. This represents 0.13% of its overall portfolio holdings.
Number of Shares
10,013
Previous 10,000
0.13%
Holding current value
$204,765
Previous $117,000
25.64%
% of portfolio
0.13%
Previous 0.1%
Shares
4 transactions
Others Institutions Holding LQDA
# of Institutions
192Shares Held
46.5MCall Options Held
473KPut Options Held
464K-
Black Rock Inc. New York, NY4.24MShares$86.7 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.99MShares$81.6 Million0.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$70.9 Million0.0% of portfolio
-
Findell Capital Management LLC New York, NY2.89MShares$59.1 Million20.5% of portfolio
-
Opaleye Management Inc. Boston, MA2.26MShares$46.2 Million9.17% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $1.32B
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...